ACET – adicet bio, inc. (US:NASDAQ)
Stock Stats
News
Adicet Bio, Inc. (NASDAQ: ACET) was downgraded by analysts at StockNews.com from a "hold" rating to a "sell" rating.
Adicet Opens Enrollment for ADI-270 Phase 1 Clinical Trial in Metastatic/Advanced Clear Cell Renal Cell Carcinoma
Adicet Bio, Inc. (NASDAQ: ACET) had its "neutral" rating re-affirmed by analysts at HC Wainwright.
Adicet Bio Announces First Lupus Nephritis Patient Dosed in Phase 1 Clinical Trial of ADI-001 in Autoimmune Diseases [Yahoo! Finance]
Adicet Bio Announces First Lupus Nephritis Patient Dosed in Phase 1 Clinical Trial of ADI-001 in Autoimmune Diseases
Form 8-K Adicet Bio, Inc. For: Nov 18
Form 8-K Adicet Bio, Inc. For: Nov 08
Form SC 13G/A Adicet Bio, Inc. Filed by: RA CAPITAL MANAGEMENT, L.P.
Form SC 13G/A Adicet Bio, Inc. Filed by: COMMODORE CAPITAL LP
Form SC 13G/A Adicet Bio, Inc. Filed by: TANG CAPITAL MANAGEMENT LLC
Live Event: How Top Hedge Funds Use News To Make Money From The Stock Market & How Ordinary People Are Copying Their Strategies
If you could use the news to make money from the stock market, would you? Join us on our live online event where you’ll discover this simple scientific method that has allowed ordinary people get a huge return from the stock market without excessive risk.